Latest FCPM III SERVICES B.V. Stock Portfolio
FCPM III SERVICES B.V. Performance:
2025 Q4: 11.72%YTD: -5.7%2024: 65.07%
Performance for 2025 Q4 is 11.72%, and YTD is -5.7%, and 2024 is 65.07%.
About FCPM III SERVICES B.V. and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, FCPM III SERVICES B.V. reported an equity portfolio of $762.9 Millions as of 31 Dec, 2025.
The top stock holdings of FCPM III SERVICES B.V. are NAMS, DYN, . The fund has invested 42.3% of it's portfolio in NEWAMSTERDAM PHARMA COMPANY and 14% of portfolio in DYNE THERAPEUTICS INC.
The fund managers got completely rid off ASTRIA THERAPEUTICS INC (ATXS) stocks. They significantly reduced their stock positions in REPLIMUNE GROUP INC (REPL) and NEWAMSTERDAM PHARMA COMPANY (NAMS). FCPM III SERVICES B.V. opened new stock positions in MAPLIGHT THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to VOR BIOPHARMA INC (VOR), RAPT THERAPEUTICS INC (RAPT) and BICYCLE THERAPEUTICS PLC (BCYC).
The top stock holdings of FCPM III SERVICES B.V. are NAMS, DYN, . The fund has invested 42.3% of it's portfolio in NEWAMSTERDAM PHARMA COMPANY and 14% of portfolio in DYNE THERAPEUTICS INC.
The fund managers got completely rid off ASTRIA THERAPEUTICS INC (ATXS) stocks. They significantly reduced their stock positions in REPLIMUNE GROUP INC (REPL) and NEWAMSTERDAM PHARMA COMPANY (NAMS). FCPM III SERVICES B.V. opened new stock positions in MAPLIGHT THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to VOR BIOPHARMA INC (VOR), RAPT THERAPEUTICS INC (RAPT) and BICYCLE THERAPEUTICS PLC (BCYC).
FCPM III SERVICES B.V. Annual Return Estimates Vs S&P 500
Our best estimate is that FCPM III SERVICES B.V. made a return of 11.72% in the last quarter. In trailing 12 months, it's portfolio return was -5.7%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| maplight therapeutics inc | 56,671,700 |
| crescent biopharma inc. | 19,899,300 |
New stocks bought by FCPM III SERVICES B.V.
Additions
| Ticker | % Inc. |
|---|---|
| vor biopharma inc | 852 |
| rapt therapeutics inc | 432 |
| bicycle therapeutics plc | 0.47 |
Additions to existing portfolio by FCPM III SERVICES B.V.
Reductions
| Ticker | % Reduced |
|---|---|
| replimune group inc | -32.46 |
| newamsterdam pharma company | -0.15 |
FCPM III SERVICES B.V. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| astria therapeutics inc | -29,902,900 |
FCPM III SERVICES B.V. got rid off the above stocks
Sector Distribution
FCPM III SERVICES B.V. has about 64.9% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 64.9 |
| Healthcare | 35.1 |
Market Cap. Distribution
FCPM III SERVICES B.V. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- SMALL-CAP
- MID-CAP
- MICRO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 64.9 |
| SMALL-CAP | 14.9 |
| MID-CAP | 14 |
| MICRO-CAP | 6.2 |
Stocks belong to which Index?
About 31.9% of the stocks held by FCPM III SERVICES B.V. either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 68.1 |
| RUSSELL 2000 | 31.9 |
FCPM III SERVICES B.V. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of FCPM III SERVICES B.V.
FCPM III SERVICES B.V. has 10 stocks in it's portfolio. VOR proved to be the most loss making stock for the portfolio. NAMS was the most profitable stock for FCPM III SERVICES B.V. last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCYC | bicycle therapeutics plc | 3.22 | 3,468,430 | 24,556,500 | added | 0.47 | ||
| DYN | dyne therapeutics inc | 14.01 | 5,462,850 | 106,853,000 | unchanged | 0.00 | ||
| NAMS | newamsterdam pharma company | 42.30 | 9,198,900 | 322,697,000 | reduced | -0.15 | ||
| RAPT | rapt therapeutics inc | 8.14 | 1,833,330 | 62,095,000 | added | 432 | ||
| REPL | replimune group inc | 3.58 | 2,808,370 | 27,297,300 | reduced | -32.46 | ||
| VOR | vor biopharma inc | 6.20 | 3,617,350 | 47,315,000 | added | 852 | ||
| engene holdings inc | 11.40 | 9,632,560 | 86,982,000 | unchanged | 0.00 | |||
| maplight therapeutics inc | 7.43 | 3,226,400 | 56,671,700 | new | ||||
| crescent biopharma inc. | 2.61 | 1,677,850 | 19,899,300 | new | ||||
| engene holdings inc | 1.12 | 2,878,150 | 8,519,320 | unchanged | 0.00 | |||